A Distress Reduction Intervention for Patients With BCR-ABL-Negative MPNs or CML on Tyrosine Kinase Inhibitors

Inclusion Criteria:

* PATIENT: Carry a diagnosis of BCR-ABL-negative MPN or CML
* PATIENT: Have an estimated life expectancy of at least 6 months, assessed by principal investigator or treating investigator
* PATIENT: Be able to speak and read English
* PATIENT: Be able to navigate websites, fill out forms on the web, communicate by email, and have regular access to the internet (assessed by participant self-report)
* PATIENT: Have daily access to a mobile phone capable of receiving text messages, as determined by a study investigator
* PATIENT: Be able to provide informed consent
* CAREGIVER: Be a spouse/partner, other family member, or a close friend of a BCR-ABL-negative patient who consented to participate in the Being Present-MPN study
* CAREGIVER: Be able to speak and read English
* CAREGIVER: Be able to navigate websites, fill out forms on the web, communicate by email, and have regular access to the internet (assessed by participant self-report)
* CAREGIVER: Have access to a mobile phone capable of receiving text messages, as determined by a study investigator
* CAREGIVER: Be able to provide informed consent

Exclusion Criteria:

* PATIENT: Have had their BCR-ABL-negative MPN transform into acute leukemia
* PATIENT: Have had their CP-CML transform into blast phase
* PATIENT: Be post-allogeneic stem cell transplantation
* PATIENT AND CAREGIVER: Have extensive hearing loss such that ability to participate in the study would be impaired